Format

Send to

Choose Destination
Int J Health Serv. 2008;38(4):731-50.

The benefits and savings from publicly funded clinical trials of prescription drugs.

Author information

1
Center for Economic and Policy Research, Washington, DC 20009, USA. dean.baker1@verizon.net

Abstract

The current system of financing for clinical drug trials creates numerous perverse incentives. Since the trials are typically performed or controlled by the company who owns the patent, it has enormous incentives to report positive findings and conceal results that indicate the drug might be ineffective or even harmful. In addition, the large patent rents earned by drug companies are justified by the need to recoup research costs, approximately half of which are attributable to clinical trials. This article outlines a system of publicly financed clinical trials under which all results are fully available to the public. The system would be financed by paying lower drug prices under the Medicare drug program and other public health care programs.

PMID:
19069290
DOI:
10.2190/HS.38.4.i
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center